{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:24:40Z","timestamp":1786944280811,"version":"build-2736575974"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has emerged as one of the major chronic liver diseases worldwide, and its progression mechanisms have not yet been fully elucidated. Ferroptosis is a form of programmed cell death driven by iron-dependent lipid peroxidation. In recent years, it has been demonstrated to play a crucial regulatory role in the progression of MASLD. Although publications on MASLD have increased rapidly over the past decade, there is currently a lack of systematic bibliometric analysis regarding research trends, emerging hotspots, and global contributions in this field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Articles and reviews related to MASLD and ferroptosis were retrieved from the Web of Science Core Collection (WoSCC), PubMed and Scopus. Then duplicate literature and irrelevant literature were removed by Noteexpress software. R software, CiteSpace, VOSviewer and Pajek were employed to analyse and visualise the included literature. Specifically, we examined publication year, country, institution, journal, author, references, and keywords to identify the research landscape and evolutionary trajectory of this field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This analysis encompassed 373 publications on ferroptosis in MASLD, spanning the period from 2018 to 2026. In the past 4\u00a0years, 294 publications were published, accounting for 78.8%. China emerged as the most productive country in this field, contributing 273 publications, with Huazhong University of Science and Technology representing the core research institution.\n                      <jats:italic>Frontiers in Pharmacology<\/jats:italic>\n                      was the most influential journal with the highest number of published articles. Wang Hui was identified as the most prolific author. Keyword cluster analysis indicated that lipid peroxidation, iron homeostasis and iron overload constitute current research priorities. Emerging evidence has highlighted the dual roles of iron dysregulation and lipid peroxidation in MASLD pathogenesis, while concurrent efforts have been directed toward bridging traditional Chinese medicine and modern biomedicine in the search for novel therapeutics. Highly-cited literature consistently underscores ferroptosis as a key regulatory node in the progression of MASLD, thereby providing a novel theoretical basis and potential diagnostic-therapeutic targets for this condition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Research on the association between ferroptosis and MASLD is currently in a phase of rapid development, with research hotspots focusing on the mechanistic exploration of core regulatory pathways and their potential for clinical translation. Future efforts should prioritize strengthening international collaboration and interdisciplinary research. Through large-scale clinical trials and multi-omics data analysis, emphasis should be placed on the clinical translation of ferroptosis-targeted intervention in MASLD treatment. The results of this study may provide an important reference for selecting subsequent research directions in this field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1856946","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:35:48Z","timestamp":1786941348000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bibliometric analysis and visualization of ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD): a comprehensive review"],"prefix":"10.3389","volume":"17","author":[{"given":"Chensi","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Sheng","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Kang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Duan","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/antiox12020512","article-title":"DMF-activated Nrf2 ameliorates palmitic acid toxicity while potentiates ferroptosis mediated cell death: protective role of the NO-Donor S-Nitroso-N-Acetylcysteine","volume":"12","author":"Abu-Halaka","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/apt.18377","article-title":"A prospective study on the prevalence of MASLD in patients with type 2 diabetes and hyperferritinaemia","volume":"61","author":"Amangurbanova","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J. Inf."},{"key":"B4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/gutjnl-2023-330815","article-title":"Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease","volume":"73","author":"Armandi","year":"2024","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.tjnut.2023.04.018","article-title":"Vitamin E induces liver iron depletion and alters iron regulation in mice","volume":"153","author":"Baratz","year":"2023","journal-title":"J. Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"147995","DOI":"10.1016\/j.ijbiomac.2025.147995","article-title":"Targeting gut microbiota in non-alcoholic fatty liver disease (NAFLD): pathogenesis and therapeutic insights: a review","volume":"330","author":"Bian","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tibs.2015.11.012","article-title":"Regulators of iron homeostasis: new players in metabolism, cell death, and disease","volume":"41","author":"Bogdan","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0223994","DOI":"10.1371\/journal.pone.0223994","article-title":"Visualizing a field of research: a methodology of systematic scientometric reviews","volume":"14","author":"Chen","year":"2019","journal-title":"Plos One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/biology12060864","article-title":"The ACSL4 network regulates cell death and autophagy in diseases","volume":"12","author":"Chen","year":"2023","journal-title":"Biology-Basel"},{"key":"B12","doi-asserted-by":"publisher","first-page":"12510","DOI":"10.3390\/ijms241512510","article-title":"Icariin supplementation suppresses the markers of ferroptosis and attenuates the progression of nonalcoholic steatohepatitis in mice fed a methionine choline-deficient diet","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/nu17020229","article-title":"Coenzyme Q and selenium Co-Supplementation alleviate methionine choline-deficient diet-induced metabolic dysfunction-associated steatohepatitis in mice","volume":"17","author":"Choi","year":"2025","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","first-page":"120342","DOI":"10.1016\/j.jep.2025.120342","article-title":"Hu gan tang ameliorates metabolic-associated fatty liver disease by inhibiting ferroptosis through the Nrf2\/GPX4 pathway","volume":"353","author":"Cui","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cmet.2019.10.005","article-title":"Microbial metabolite signaling is required for systemic iron homeostasis","volume":"31","author":"Das","year":"2020","journal-title":"Cell Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41418-024-01322-5","article-title":"MafG\/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells","volume":"31","author":"Deng","year":"","journal-title":"Cell Death Differ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"117320","DOI":"10.1016\/j.jep.2023.117320","article-title":"Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling","volume":"319","author":"Deng","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol. Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10565-024-09953-7","article-title":"Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway","volume":"40","author":"Feng","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.apsb.2024.02.017","article-title":"A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment","volume":"14","author":"Fu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"B24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","article-title":"Mechanisms controlling cellular and systemic iron homeostasis","volume":"25","author":"Galy","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11418-021-01491-4","article-title":"Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1\/Nrf2-ARE signaling pathway to reduce ferroptosis","volume":"75","author":"Gao","year":"2021","journal-title":"J. Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","article-title":"Lytic cell death in metabolic liver disease","volume":"73","author":"Gautheron","year":"2020","journal-title":"J. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"124479","DOI":"10.1016\/j.saa.2024.124479","article-title":"Near-infrared lipid droplets polarity fluorescent probe for early diagnosis of nonalcoholic fatty liver disease","volume":"318","author":"Ge","year":"2024","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.7150\/ijbs.85883","article-title":"Melatonin ameliorates hepatic ferroptosis in NAFLD by inhibiting ER stress via the MT2\/cAMP\/PKA\/IRE1 signaling pathway","volume":"19","author":"Guan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"117114","DOI":"10.1016\/j.bone.2024.117114","article-title":"Berberine ameliorates nonalcoholic fatty liver disease-induced bone loss by inhibiting ferroptosis","volume":"185","author":"Gu","year":"2024","journal-title":"Bone"},{"key":"B32","doi-asserted-by":"publisher","first-page":"156806","DOI":"10.1016\/j.phymed.025.156806","article-title":"Camellia japonica radix modulates gut microbiota and 9(S)-HpODE-medi-ated ferroptosis to alleviate oxidative stress against MASLD","volume":"143","author":"Gu","year":"","journal-title":"Phytomedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"156806","DOI":"10.1016\/j.phymed.2025.156806","article-title":"Camellia japonica radix modulates gut microbiota and 9(S)-HpODE-mediated ferroptosis to alleviate oxidative stress against MASLD","volume":"143","author":"Gu","year":"","journal-title":"Phytomedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","article-title":"Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis","volume":"29","author":"Guo","year":"2023","journal-title":"Mol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semcdb.2020.12.005","article-title":"Iron in immune cell function and host defense","volume":"115","author":"Haschka","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","article-title":"ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis","volume":"79","author":"He","year":"2023","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10616-025-00737-3","article-title":"Yunnan medicine jiangzhi ointment alleviates hyperlipid-induced hepatocyte ferroptosis by activating AMPK and promoting autophagy","volume":"77","author":"Hong","year":"2025","journal-title":"Cytotechnology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.3390\/nu15204375","article-title":"Partial replacement of diet with dehulled adlay ameliorates hepatic steatosis, inflammation, oxidative stress, and gut dysbiosis in rats with nonalcoholic fatty liver disease","volume":"15","author":"Huang","year":"2023","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","article-title":"SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis","volume":"22","author":"Jenkitkasemwong","year":"2015","journal-title":"Cell Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.14218\/JCTH.2022.00136","article-title":"The gut microbiome and ferroptosis in MAFLD","volume":"11","author":"Ji","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"102963","DOI":"10.1016\/j.redx.2023.102963","article-title":"Arbutin alleviates fatty liver inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"","journal-title":"Redox Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"102963","DOI":"10.1016\/j.redox.2023.102963","article-title":"Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"","journal-title":"Redox Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"159628","DOI":"10.1016\/j.bbalip.2025.159628","article-title":"Oroxylin A ameliorates non-alcoholic fatty liver disease by modulating oxidative stress and ferroptosis through the Nrf2 pathway","volume":"1870","author":"Jiang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcb.29870","article-title":"Identification and initial characterization of a potent inhibitor of ferroptosis","volume":"122","author":"Kuganesan","year":"2021","journal-title":"J. Cell Biochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"117100","DOI":"10.1016\/j.bcp.2025.117100","article-title":"(-)-Epicatechin targets early growth response protein 1, an inflammation-associated ferroptosis regulator, to ameliorate metabolic dysfunction-associated steatotic liver disease","volume":"240","author":"Li","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.nutres.2024.09.011","article-title":"Epidemiological and transcriptome data identify association between iron overload and metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis","volume":"131","author":"Li","year":"2024","journal-title":"Nutr. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4777789","DOI":"10.1155\/2024\/4777789","article-title":"The AMPK-mTOR pathway is inhibited by chaihu shugan powder, which relieves nonalcoholic steatohepatitis by suppressing autophagic ferroptosis","volume":"2024","author":"Liang","year":"2024","journal-title":"Mediat. Inflamm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.freeradbiomed.2022.10.270","article-title":"The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD","volume":"193","author":"Liu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"159287","DOI":"10.1016\/j.bbalip.2023.159287","article-title":"Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells","volume":"1868","author":"Liu","year":"2023","journal-title":"Biochimica Biophysica Acta-Molecular Cell Biol. Lipids"},{"key":"B54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13020-025-01121-1","article-title":"The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease","volume":"20","author":"Liu","year":"","journal-title":"Chin. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e70589","DOI":"10.1002\/fsn3.70589","article-title":"Fucoxanthin ameliorates carbon tetrachloride-induced liver fibrosis in mice via Nrf2\/HO-1\/GPX4-Mediated ferroptosis pathway","volume":"13","author":"Liu","year":"","journal-title":"Food Sci. Nutr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/s0168-8278(01)00192-1","article-title":"Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects","volume":"35","author":"Loguercio","year":"2001","journal-title":"J. Hepatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/metabo16030203","article-title":"Malondialdehyde as a predictor of disease severity and cardiovascular risk in population with metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Lugo","year":"2026","journal-title":"Metabolites"},{"key":"B58","doi-asserted-by":"publisher","first-page":"103159","DOI":"10.1016\/j.redox.2024.103159","article-title":"SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression","volume":"72","author":"Lv","year":"2024","journal-title":"Redox Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/13880209.2023.2189908","article-title":"Schisandrin B promotes senescence of activated hepatic stellate cell via NCOA4-mediated ferritinophagy","volume":"61","author":"Ma","year":"2023","journal-title":"Pharm. Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1021\/acs.jafc.5c05877","article-title":"Mechanistic elucidation of Tricholoma mongolicum polysaccharides in treating MAFLD via regulation of the gut microbiota-metabolite-ferroptosis axis: a multi-omics perspective","volume":"73","author":"Ma","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/antiox13070805","article-title":"Apomorphine suppresses the progression of steatohepatitis by inhibiting ferroptosis","volume":"13","author":"Maeda","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"22244","DOI":"10.1074\/jbc.M110.121327","article-title":"System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency","volume":"285","author":"Mandal","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ncrna.2024.10.002","article-title":"Innovative approaches to metabolic dysfunction-associated steatohepatitis diagnosis and stratification","volume":"10","author":"Matboli","year":"2025","journal-title":"Noncoding RNA Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"103858","DOI":"10.1016\/j.redox.2025.103858","article-title":"Monitoring ferroptosis in vivo: iron-Driven volatile oxidized lipids as breath biomarkers","volume":"86","author":"Matsuoka","year":"2025","journal-title":"Redox Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s2468-1253(22)00062-0","article-title":"Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"117185","DOI":"10.1016\/j.taap.2024.117185","article-title":"A computational model of the crosstalk between hepatocyte fatty acid metabolism and oxidative stress highlights the key enzymes, metabolites, and detoxification pathways in the context of MASLD","volume":"495","author":"Miura","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"20800","DOI":"10.1021\/acsomega.0c01689","article-title":"Epigallocatechin gallate protects mice against methionine-choline-deficient-diet-induced nonalcoholic steatohepatitis by improving gut microbiota to attenuate hepatic injury and regulate metabolism","volume":"5","author":"Ning","year":"2020","journal-title":"Acs Omega"},{"key":"B70","doi-asserted-by":"publisher","first-page":"10969","DOI":"10.2147\/jir.s532630","article-title":"Mechanism of lipi jiangzhuo decoction in improving metabolic dysfunction-associated steatohepatitis through the PERK\/PINK1\/GPx4 pathway","volume":"18","author":"Pan","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.fct.2015.03.029","article-title":"Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection","volume":"80","author":"Pardo","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"12862","DOI":"10.3390\/ijms241612862","article-title":"Pharmacological prevention of ectopic erythrophagocytosis by cilostazol mitigates ferroptosis in NASH","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41418-024-01348-9","article-title":"Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Peleman","year":"2024","journal-title":"Cell Death Differ."},{"key":"B74","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.3390\/ijms252011112","article-title":"Atractylodes lancea rhizome polysaccharide alleviates MCD diet-induced NASH by inhibiting the p53\/mTOR pathway","volume":"25","author":"Pi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mam.2007.09.016","article-title":"4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases","volume":"29","author":"Poli","year":"2008","journal-title":"Mol. Asp. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/hep.31328","article-title":"Iron chaperone poly rC binding protein 1 protects mouse liver from lipid peroxidation and steatosis","volume":"73","author":"Protchenko","year":"2021","journal-title":"Hepatology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","article-title":"Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice","volume":"190","author":"Qi","year":"2020","journal-title":"Am. J. Pathol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","article-title":"Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis","volume":"187","author":"Qiu","year":"","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"24417","DOI":"10.1021\/acs.jafc.4c04929","article-title":"Nuciferine alleviates high-fat Diet- and ApoE(-\/-)-Induced hepatic steatosis and ferroptosis in NAFLD mice via the PPAR\u03b1 signaling pathway","volume":"72","author":"Qiu","year":"","journal-title":"J. Agric. Food Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13020-025-01109-x","article-title":"Quercetagetin alleviates liver fibrosis in non-alcoholic fatty liver disease by promoting ferroptosis of hepatic stellate cells through GPX4 ubiquitination","volume":"20","author":"Qiu","year":"2025","journal-title":"Chin. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1554850","DOI":"10.3389\/fphar.2025.1554850","article-title":"Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPAR\u03b1","volume":"16","author":"Ren","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20230128","article-title":"Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model","volume":"43","author":"Saha","year":"2023","journal-title":"Biosci. Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-Mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"key":"B87","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s0168-8278(02)00073-9","article-title":"In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases","volume":"37","author":"Seki","year":"2002","journal-title":"J. Hepatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"9999612","DOI":"10.1155\/2021\/9999612","article-title":"Mechanism of ferroptosis and its role in type 2 diabetes mellitus","volume":"2021","author":"Sha","year":"2021","journal-title":"J. Diabetes Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cmet.2008.12.012","article-title":"Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency","volume":"9","author":"Shah","year":"2009","journal-title":"Cell Metab."},{"key":"B90","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.3390\/ijms21249682","article-title":"Cell death in liver diseases: a review","volume":"21","author":"Shojaie","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e70569","DOI":"10.1111\/liv.70569","article-title":"Prevalence and characteristics of hyperferritinemia in metabolic dysfunction-associated steatotic liver disease: a meta-analysis","volume":"46","author":"Souza","year":"2026","journal-title":"Liver Int."},{"key":"B92","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.cmet.2024.07.013","article-title":"Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH","volume":"36","author":"Tao","year":"2024","journal-title":"Cell Metab."},{"key":"B95","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","article-title":"Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis","volume":"44","author":"Tong","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"B97","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s4119-019-1678-y","article-title":"Hepatic ferroptosis plays an important role the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"","journal-title":"Cell Death and Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"","journal-title":"Cell Death Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: vosviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B100","doi-asserted-by":"publisher","first-page":"934989","DOI":"10.3389\/fmed.2022.934989","article-title":"Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: a systematic review","volume":"9","author":"Wang","year":"","journal-title":"Front. Med. (Lausanne)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41420-022-01011-7","article-title":"Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis","volume":"8","author":"Wang","year":"","journal-title":"Cell Death Discov."},{"key":"B102","doi-asserted-by":"publisher","first-page":"113025","DOI":"10.1016\/j.intimp.2024.113025","article-title":"Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: targeting ferroptosis and lipid metabolism disorders","volume":"142","author":"Wang","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5356","article-title":"Research progress, challenges and perspectives of phospholipids metabolism in the LXR-LPCAT3 signaling pathway and its relation to NAFLD","volume":"53","author":"Wang","year":"","journal-title":"Int. J. Mol. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s10020-024-01003-6","article-title":"Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice","volume":"30","author":"Wang","year":"","journal-title":"Mol. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"109886","DOI":"10.1016\/j.jnutbio.2025.109886","article-title":"Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive system","volume":"140","author":"Wang","year":"","journal-title":"J. Nutr. Biochem."},{"key":"B106","doi-asserted-by":"publisher","first-page":"156712","DOI":"10.1016\/j.phymed.2025.156712","article-title":"Multi-approach analysis reveals the mechanism by which shugan xiaozhi decoction protects against metabolic dysfunction-associated steatohepatitis","volume":"141","author":"Wang","year":"","journal-title":"Phytomedicine"},{"key":"B107","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","article-title":"Ferroptosis in liver disease: new insights into disease mechanisms","volume":"7","author":"Wu","year":"2021","journal-title":"Cell Death Discov."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1118449","DOI":"10.3389\/fimmu.2023.1118449","article-title":"Programmed cell death and lipid metabolism of macrophages in NAFLD","volume":"14","author":"Xiao","year":"2023","journal-title":"Front. Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of ferroptosis and relevance to cardiovascular disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1344971","DOI":"10.3389\/fendo.2024.1344971","article-title":"Hypoxia-inducible factor-2\u03b1 promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells","volume":"15","author":"Yan","year":"","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/biomedicines12122728","article-title":"Echinacoside alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis via Nrf2\/HMOX1 pathway","volume":"12","author":"Yan","year":"","journal-title":"Biomedicines"},{"key":"B112","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B113","doi-asserted-by":"publisher","first-page":"152599","DOI":"10.1016\/j.tox.2020.152599","article-title":"Study on the attenuated effect of ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease","volume":"445","author":"Yang","year":"2020","journal-title":"Toxicology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"342747","DOI":"10.1016\/j.aca.2024.342747","article-title":"Multifunctional lipid droplet probes for observing the polarity change of ferroptosis, inflammation, fatty liver and evaluating the efficacy of drugs","volume":"1312","author":"Yang","year":"","journal-title":"Anal. Chim. Acta"},{"key":"B115","doi-asserted-by":"publisher","first-page":"102408","DOI":"10.1016\/j.mtchem.2024.102408","article-title":"Application of a wash-free NIR-Fluorescent probe in detecting the polarity of lipid droplets and identifying NAFLD","volume":"42","author":"Yang","year":"","journal-title":"Mater. Today Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"e18321","DOI":"10.1016\/j.heliyon.2023.e18321","article-title":"Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis","volume":"9","author":"Ye","year":"2023","journal-title":"Heliyon"},{"key":"B117","doi-asserted-by":"publisher","first-page":"156472","DOI":"10.1016\/j.phymed.2025.156472","article-title":"Hinokitiol ameliorates MASH in mice by therapeutic targeting of hepatic Nrf2 and inhibiting hepatocyte ferroptosis","volume":"139","author":"Yin","year":"2025","journal-title":"Phytomedicine"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1431652","DOI":"10.3389\/fendo.2024.1431652","article-title":"Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B120","doi-asserted-by":"publisher","first-page":"134779","DOI":"10.1016\/j.ijbiomac.2024.134779","article-title":"GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis","volume":"278","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"108560","DOI":"10.1016\/j.isci.2023.108560","article-title":"Metformin alleviates hepatic iron overload and ferroptosis through AMPK-Ferroportin pathway in HFD-Induced NAFLD","volume":"26","author":"Yue","year":"2023","journal-title":"iScience"},{"key":"B122","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/antiox9070578","article-title":"Serum malondialdehyde is associated with non-alcoholic fatty liver and related liver damage differentially in men and women","volume":"9","author":"Zelber-Sagi","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B123","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1111\/dom.15945","article-title":"Diosgenin ameliorating non-alcoholic fatty liver disease via Nrf2-mediated regulation of oxidative stress and ferroptosis","volume":"26","author":"Zhang","year":"","journal-title":"Diabetes Obes. Metab."},{"key":"B125","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2025.06.042","article-title":"Lactobacillus plantarum 1-2-3 inhibits ferroptosis by regulating dysregulated fatty acid metabolism to protect mice from high-fat diet-induced MAFLD","volume":"238","author":"Zhang","year":"","journal-title":"Free Radic. Biol. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e2500467","DOI":"10.1002\/adhm.202500467","article-title":"Biomimetic selenium-nanocomposites alleviate MASH by modulating lipid and iron homeostasis","volume":"14","author":"Zhang","year":"","journal-title":"Adv. Healthc. Mater"},{"key":"B127","doi-asserted-by":"publisher","first-page":"122230","DOI":"10.1016\/j.biomaterials.2023.122230","article-title":"Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery","volume":"301","author":"Zhao","year":"2023","journal-title":"Biomaterials"},{"key":"B128","doi-asserted-by":"publisher","first-page":"117089","DOI":"10.1016\/j.bcp.2025.117089","article-title":"Ghrelin attenuates metabolic dysfunction-associated steatotic liver disease by activating glutamine metabolism via inhibition of the IRE1\u03b1-XBP-1 pathway","volume":"240","author":"Zhao","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"key":"B130","doi-asserted-by":"publisher","first-page":"174351","DOI":"10.1016\/j.ejphr.2021.174351","article-title":"Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation GPX4","volume":"908","author":"Zhu","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"174351","DOI":"10.1016\/j.ejphar.2021.174351","article-title":"Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4","volume":"908","author":"Zhu","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1286449","DOI":"10.3389\/fphar.2023.1286449","article-title":"Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.cbi.2024.111162","article-title":"Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway","volume":"400","author":"Zhu","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"B134","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13148-025-01813-3","article-title":"TEC-Mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis","volume":"17","author":"Zhu","year":"2025","journal-title":"Clin. Epigenetics"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1856946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:35:56Z","timestamp":1786941356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1856946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":134,"alternative-id":["10.3389\/fphar.2026.1856946"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1856946","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1856946"}}